BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review. Neurosci Biobehav Rev 2020;112:227-41. [PMID: 32032654 DOI: 10.1016/j.neubiorev.2020.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chu C, Yu L, Chen W, Tian F, Zhai Q. Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis. Trends in Food Science & Technology 2021;116:90-101. [DOI: 10.1016/j.tifs.2021.07.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vuuren MJV, Nell TA, Carr JA, Kell DB, Pretorius E. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease. Biomolecules 2020;11:E30. [PMID: 33383805 DOI: 10.3390/biom11010030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Reference Citation Analysis]
4 Safarpour D, Sharzehi K, Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs. [DOI: 10.1007/s40265-021-01664-1] [Reference Citation Analysis]
5 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021:S1742-7061(21)00229-4. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gentile F, Doneddu PE, Riva N, Nobile-Orazio E, Quattrini A. Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. Int J Mol Sci 2020;21:E7471. [PMID: 33050475 DOI: 10.3390/ijms21207471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Sun Y, Zhong S, Deng B, Jin Q, Wu J, Huo J, Zhu J, Zhang C, Li Y. Impact of Phellinus gilvus mycelia on growth, immunity and fecal microbiota in weaned piglets. PeerJ 2020;8:e9067. [PMID: 32377455 DOI: 10.7717/peerj.9067] [Reference Citation Analysis]
8 Shen S, Zhang C, Xu YM, Shi CH. The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications. J Parkinsons Dis 2021. [PMID: 34719435 DOI: 10.3233/JPD-212929] [Reference Citation Analysis]
9 Li Y, Shao L, Mou Y, Zhang Y, Ping Y. Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer's disease and their potential links in the pathogenesis. Gut Microbes 2021;13:1957407. [PMID: 34520319 DOI: 10.1080/19490976.2021.1957407] [Reference Citation Analysis]
10 Zhang H, Chen Y, Wang Z, Xie G, Liu M, Yuan B, Chai H, Wang W, Cheng P. Implications of Gut Microbiota in Neurodegenerative Diseases. Front Immunol 2022;13:785644. [DOI: 10.3389/fimmu.2022.785644] [Reference Citation Analysis]
11 Dumitrescu L, Marta D, Dănău A, Lefter A, Tulbă D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease. Front Neurosci 2021;15:689723. [PMID: 34220443 DOI: 10.3389/fnins.2021.689723] [Reference Citation Analysis]
12 Tizabi Y, Getachew B, Aschner M. Novel Pharmacotherapies in Parkinson's Disease. Neurotox Res 2021;39:1381-90. [PMID: 34003454 DOI: 10.1007/s12640-021-00375-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Getachew B, Csoka AB, Bhatti A, Copeland RL, Tizabi Y. Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease. Neurotox Res 2020;38:596-602. [PMID: 32572814 DOI: 10.1007/s12640-020-00238-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
14 Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, Tansey MG. Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation. Mov Disord 2021;36:25-36. [PMID: 33314312 DOI: 10.1002/mds.28411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 McGuinness AJ, Davis JA, Dawson SL, Loughman A, Collier F, O'Hely M, Simpson CA, Green J, Marx W, Hair C, Guest G, Mohebbi M, Berk M, Stupart D, Watters D, Jacka FN. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry 2022. [PMID: 35194166 DOI: 10.1038/s41380-022-01456-3] [Reference Citation Analysis]
16 Liang Y, Cui L, Gao J, Zhu M, Zhang Y, Zhang HL. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment. Mol Neurobiol 2021;58:3745-58. [PMID: 33825149 DOI: 10.1007/s12035-021-02375-0] [Reference Citation Analysis]
17 Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. The gut microbiota in anxiety and depression - A systematic review. Clin Psychol Rev 2021;83:101943. [PMID: 33271426 DOI: 10.1016/j.cpr.2020.101943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
18 Han D, Gao P, Li R, Tan P, Xie J, Zhang R, Li J. Multicenter assessment of microbial community profiling using 16S rRNA gene sequencing and shotgun metagenomic sequencing. J Adv Res 2020;26:111-21. [PMID: 33133687 DOI: 10.1016/j.jare.2020.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
19 Dong R, Lin H, Chen X, Shi R, Yuan S, Li J, Zhu B, Xu X, Shen W, Wang K, Shu XO, Ding D, He N. Gut Microbiota and Fecal Metabolites Associated With Neurocognitive Impairment in HIV-Infected Population. Front Cell Infect Microbiol 2021;11:723840. [PMID: 34760715 DOI: 10.3389/fcimb.2021.723840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease. Mol Neurodegener 2021;16:6. [PMID: 33557896 DOI: 10.1186/s13024-021-00427-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Ren X, Chen JF. Caffeine and Parkinson's Disease: Multiple Benefits and Emerging Mechanisms. Front Neurosci 2020;14:602697. [PMID: 33390888 DOI: 10.3389/fnins.2020.602697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]